Biogen Inc
NASDAQ: BIIB
$164.89
-$0.90 (-0.5%)
Closing Price on November 14, 2024
BIIB Articles
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday, include Best Buy, Caterpillar, Nokia, UnitedHealth and Wal-Mart.
Published:
Last Updated:
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Published:
Last Updated:
A few biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off.
Published:
Last Updated:
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
Thursday’s top analyst upgrades, downgrades and initiations include Biogen, Comerica, Deere, NVIDIA and Twenty-First Century Fox.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Published:
Last Updated:
Tuesday’s top analyst upgrades, downgrades and initiations include Biogen, FedEx, Lionsgate Entertainment, Rexnord and RoadRunner Transportation.
Published:
Last Updated:
In a new research report, the biotech team at RBC reveal their top picks for 2017, and while hardly pounding the table, they are cautiously optimistic.
Published:
Last Updated:
Friday's top analyst upgrades, downgrades and initiations include Apple, Biogen, FedEx, General Electric and Las Vegas Sands.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous report, and short interest was mixed in the selected biotech stocks.
Published:
Last Updated:
Friday’s top analyst upgrades, downgrades and initiations include Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines and Finisar.
Published:
Last Updated:
The November 15 short interest data have been compared with the previous report, and short interest increased in most of the selected biotech stocks.
Published:
Last Updated:
Now that the U.S. presidential election is over and Hillary Clinton is out of the picture, major biotech companies can breathe a little easier knowing that the pressure is off, if for just now at...
Published:
Last Updated: